About Amplexa
Amplexa is a company based in Odense (Denmark) founded in 2006 by Hans Atli Dahl. It operates as a B2B and Service-based. The company has 17 employees as of November 30, 2024. Amplexa offers products and services including Fertility Testing, Neurology Diagnostics, Donor Screening, Technical Services, and Research and Development. Amplexa operates in a competitive market with competitors including Cordlife, Strand Life Sciences, Invitae, Genome Medical and Myriad Genetics, among others.
- Headquarter Odense, Denmark
- Employees 17 as on 30 Nov, 2024
- Founders Hans Atli Dahl
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Amplexa Genetics A/S
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
17
as on Nov 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Amplexa
Amplexa offers a comprehensive portfolio of products and services, including Fertility Testing, Neurology Diagnostics, Donor Screening, Technical Services, and Research and Development.
Provides tests to enhance success in fertility treatments
Offers tests for epilepsy and intellectual disabilities
Screens donors for safety in family planning
Delivers bioinformatics and data analysis for research
Assists in sequencing methodologies and experiment setup
Funding Insights of Amplexa
Detailed funding history for Amplexa
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Amplexa
Investment portfolio details for Amplexa
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Amplexa
Detailed financials for Amplexa
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Amplexa Comparisons
Peer comparison for Amplexa
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Amplexa
Amplexa operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cordlife, Strand Life Sciences, Invitae, Genome Medical and Myriad Genetics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cordlife is engaged in cord blood banking and diagnostics.
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Home-based genetic tests for detecting diseases are provided to individuals.
|
|
| Locked | Locked | Locked |
Genomic testing services are provided clinically and directly to consumers.
|
|
| Locked | Locked | Locked |
Molecular diagnostics and personalized medicine for cancer are developed.
|
|
| Locked | Locked | Locked |
Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer
|
Detailed competitors of Amplexa
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Amplexa
Complete news archive for Amplexa
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amplexa
Amplexa was founded in 2006.
Amplexa is headquartered in Odense, Denmark.
Hans Atli Dahl is the current CEO of Amplexa. They have also founded this company.
As of Nov 30, 2024, the latest employee count at Amplexa is 17.
Amplexa Genetics, based in Odense C, Denmark, specializes in advanced genetic testing to support doctors in diagnosing and treating patients. They provide services for fertility treatments, neurology diagnostics, and research development, including technical sequencing and bioinformatics. Their solutions help clinics and researchers with comprehensive tests and data analysis for better patient outcomes and scientific advancements.
Amplexa's top competitors include Strand Life Sciences, Cordlife and Fulgent Genetics.
Amplexa offers Fertility Testing, Neurology Diagnostics, Donor Screening, Technical Services, and Research and Development.